Fig 2. Vaccination status for children 1–4 years old, by vaccine.

Results are presented for the original community-based measles serological survey and missed populations study, Ndola and Choma Districts, Zambia, 2022. The vaccines considered are bacille Calmette-Guérin, BCG; the first, second, and third dose of diphtheria, pertussis, and tetanus (Penta1, Penta2, Penta3); and first and second doses of measles-containing vaccine (MCV1, MCV2).